Phlebolymphology N°118

Phlebolymphology N°118 – Editorial

Dear Readers, This issue explores an important topic: therapeutic interventions targeting deep venous involvement that affects the overall condition of patients with oncological disease and may shorten their life expectancy. Unlike conventional procedures, the goal is not to achieve long-term technical success but primarily to relieve disabling symptoms. Significant venous involvement impacting overall health in cancer patients can mainly present in 2 forms: acute and chronic. The first involves episodes of acute or subacute venous thrombosis, with or without pulmonary embolism. The second results from obstructed venous outflow, which may be caused by intrinsic factors or external compression. M. J….

Full text

Phlebolymphology N°118 (Vol 32 – N°3 – 2025)

Editorial PHLEBOLOGY Early thrombus removal in the oncology patient Matthew J. MULLINS (Ireland) and Gerard O’SULLIVAN (Ireland) Phlebolymphology – 2025 ; 32 (3): 82 Neoplastic obstruction of the inferior vena cava: surgical approach Alejandro RODRÍGUEZ-MORATA (Spain), Juan Pedro REYES-ORTEGA (Spain), María Luisa ROBLES-MARTÍN (Spain), Laura GALLEGO-MARTÍN (Spain) and Patricio David VITERI-ESTÉVEZ (Spain) Phlebolymphology – 2025 ; 32 (3): 92 Endovascular approach to IVC obstruction in oncological patients Olivier HARTUNG (France) Phlebolymphology – 2025 ; 32 (3): 100 Endovascular approach to neoplastic superior vena cava syndrome: a comprehensive review of stenting outcomes and advancements in management strategies Syed Mohammad HABIB (Saudi…

Full text

Endovascular approach to neoplastic superior vena cava syndrome: a comprehensive review of stenting outcomes and advancements in management strategies

Syed Mohammad Habib, MBBS College of Medicine, Sulaiman Al-Rajhi University, Al-Bukayriyah, Qassim, Saudi Arabia Reem Ali AL-Hussain, MBBS College of Medicine, Sulaiman Al-Rajhi University, Al-Bukayriyah, Qassim, Saudi Arabia Abdulmajeed Hassan Alsamsami, MBBS College of Medicine, Taif University, Taif, Saudi Arabia Almamoon I. Justaniah, MD, FSIR Interventional Radiology Section, King Faisal Specialist Hospital & Research Center – Jeddah, Saudi Arabia ABSTRACT Superior vena cava syndrome (SVCS) resulting from malignant obstruction presents significant clinical challenges requiring prompt intervention. Endovascular stenting has emerged as the primary therapeutic approach for neoplastic SVCS, demonstrating superior efficacy compared with conventional treatments. This comprehensive review synthesizes current…

Full text

Endovascular approach to IVC obstruction in oncological patients

Olivier Hartung, MD, MSc, FEBVS Department of Vascular Surgery, North University Hospital of Marseille, France ABSTRACT Cancer can cause inferior vena cava (IVC) obstruction. Usually, an oncologic resection is not possible and palliative treatment is needed. An endovascular procedure can be performed in most cases under local anesthesia plus sedation through a percutaneous approach. Stenting is a safe and the most effective technique and provides excellent technical and clinical success rates with immediate improvement of symptoms. Despite the short life expectancy of these patients, the technique allows them a far better quality of life. On the other hand, treatment of…

Full text

Neoplastic obstruction of the inferior vena cava: surgical approach

Alejandro Rodríguez-Morata, PhD, MD Angiology and Vascular Surgery Department, Quirónsalud Málaga Hospital, Spain Juan Pedro Reyes-Ortega, MD Angiology and Vascular Surgery Department, Quirónsalud Málaga Hospital, Spain María Luisa Robles-Martín, MD Angiology and Vascular Surgery Department, Quirónsalud Málaga Hospital, Spain Laura Gallego-Martín, MD Angiology and Vascular Surgery Department, Quirónsalud Málaga Hospital, Spain Patricio David Viteri-Estévez, MD Angiology and Vascular Surgery Department, Quirónsalud Málaga Hospital, Spain ABSTRACT Neoplastic obstruction of the inferior vena cava (IVC) constitutes arare but formidable challenge in both vascular and oncologic surgery.It may arise from primary tumors originating within the vessel wall,such as leiomyosarcomas, or more frequently as…

Full text

Early thrombus removal in the oncology patient

Matthew J. Mullins, MD, PhD Consultant Interventional Radiologist, Galway University, Hospital, Galway, Ireland Gerard O’Sullivan, FRCR, FRCPI, F CIRSE, F SIR Professor of Interventional Radiology, Galway University, Hospital, Galway, Ireland ABSTRACT In this review article, we will explore the treatment options and clinical considerations in the setting of hospital presentations with acute/subacute thrombosis in the oncology patient. This a complex disease spectrum that leads to significant morbidity, health care costs, and increased hospital visits and admissions over time. Cancer-associated thrombosis has become a significant cause of morbidity and potential mortality in the oncology patient. Along with challenging treatment regimens and…

Full text